Clinical Trial Update: Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and tolerability of multiple doses of ITI-214 in healthy adults and in adults with stable schizophrenia; the study is te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ITI-214

Snippet

Sponsor: Takeda | Conditions: Schizophrenia | Phase 1 | Status: TERMINATED